Thirty-Day Unplanned Hospital Readmissions in Patients With Cancer and the Impact of Social Determinants of Health: A Machine Learning Approach.
Journal
JCO clinical cancer informatics
ISSN: 2473-4276
Titre abrégé: JCO Clin Cancer Inform
Pays: United States
ID NLM: 101708809
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
pmc-release:
18
07
2024
medline:
21
7
2023
pubmed:
18
7
2023
entrez:
18
7
2023
Statut:
ppublish
Résumé
Develop a cancer-specific machine learning (ML) model that accurately predicts 30-day unplanned readmissions in patients with solid tumors. The initial cohort included patients 18 years or older diagnosed with a solid tumor. Two distinct cohorts were generated: one with and one without detailed social determinants of health (SDOHs) data. For each cohort, data were temporally partitioned in 70% (training), 20% (validation), and 10% (testing). Tree-based ML models were developed and validated on each cohort. The metrics used to evaluate the model's performance were receiver operating characteristic curve (ROC), area under the ROC curve, precision, recall (R), accuracy, and area under the precision-recall curve. We included 13,717 patients in this study in two cohorts (5,059 without SDOH data and 8,658 with SDOH data). Unplanned 30-day readmission occurred in 21.3% of the cases overall. The five main non-SDOH factors most highly associated with an unplanned 30-day readmission (R, 0.74; IQR, 0.58-0.76) were: number of previous unplanned readmissions; higher Charlson comorbidity score; nonelective index admission; discharge to anywhere other than home, hospice, or nursing facility; and higher anion gap during the admission. Neighborhood crime index, neighborhood median home values, annual income, neighborhood median household income, and wealth index were the main five SDOH factors important for predicting a high risk for an unplanned hospital readmission (R, 0.66; IQR, 0.56-0.72). The models were not directly comparable. Key drivers of unplanned readmissions in patients with cancer are complex and involve both clinical factors and SDOH. We developed a cancer-specific ML model that with reasonable accuracy identified patients with cancer at high risk for an unplanned hospital readmission.
Identifiants
pubmed: 37463363
doi: 10.1200/CCI.22.00143
pmc: PMC10569782
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2200143Références
JAMA Oncol. 2015 Jul;1(4):441-7
pubmed: 26181251
N Engl J Med. 2014 Feb 20;370(8):694-7
pubmed: 24552316
BMC Med. 2015 Jan 06;13:1
pubmed: 25563062
BMJ Open. 2018 Sep 8;8(9):e023113
pubmed: 30196269
Am J Med Qual. 2022 Jul-Aug 01;37(4):299-306
pubmed: 34935684
J Natl Cancer Inst. 2013 May 1;105(9):634-42
pubmed: 23482657
Hosp Pract (1995). 2014 Dec;42(5):34-44
pubmed: 25485916
JAMA. 2016 Jan 19;315(3):272-83
pubmed: 26784775
N Engl J Med. 2009 Apr 2;360(14):1418-28
pubmed: 19339721
JTO Clin Res Rep. 2022 Mar 09;3(4):100307
pubmed: 35400080
JCO Oncol Pract. 2022 Jan;18(1):e117-e128
pubmed: 34357793
J Geriatr Oncol. 2015 Jul;6(4):254-61
pubmed: 25976445
J Oncol Pract. 2018 May;14(5):306-313
pubmed: 29664697
Nat Mach Intell. 2020 Jan;2(1):56-67
pubmed: 32607472
JCO Clin Cancer Inform. 2021 Feb;5:155-167
pubmed: 33539176
JAMA Netw Open. 2019 Mar 1;2(3):e190348
pubmed: 30848808
Sci Rep. 2022 Mar 28;12(1):5248
pubmed: 35347189
JAMA. 2018 Apr 3;319(13):1317-1318
pubmed: 29532063
J Clin Oncol. 2017 Nov 1;35(31):3610-3617
pubmed: 28850290
J Oncol Pract. 2015 Sep;11(5):410-5
pubmed: 26152375
J Oncol Pract. 2015 Mar;11(2):126-32
pubmed: 25604597
J Geriatr Oncol. 2020 Sep;11(7):1108-1114
pubmed: 32222347
JCO Oncol Pract. 2022 Jan;18(1):7-10
pubmed: 34357787
N Engl J Med. 2008 Jan 3;358(1):95-7
pubmed: 18172185
AMIA Annu Symp Proc. 2006;:941
pubmed: 17238560
J Oncol Pract. 2016 May;12(5):e594-602
pubmed: 27048613
Open Med. 2011;5(2):e104-11
pubmed: 21915234
J Surg Oncol. 2018 May;117(6):1113-1118
pubmed: 29484659
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Ann Intern Med. 2018 Jun 5;168(11):766-774
pubmed: 29710243
N Engl J Med. 1984 Nov 22;311(21):1349-53
pubmed: 6436703
J Public Health Manag Pract. 2021 Nov-Dec 01;27(Suppl 6):S249-S257
pubmed: 33729197
Am J Public Health. 2011 Aug;101(8):1456-65
pubmed: 21680937
NPJ Precis Oncol. 2019 Feb 25;3:6
pubmed: 30820462
JAMA Intern Med. 2013 Apr 22;173(8):632-8
pubmed: 23529115
BMC Med Res Methodol. 2021 May 6;21(1):96
pubmed: 33952192
J Oncol Pract. 2019 May;15(5):e420-e427
pubmed: 30946642
Sci Rep. 2019 Feb 20;9(1):2362
pubmed: 30787351
J Clin Oncol. 2014 Feb 20;32(6):496-503
pubmed: 24419123
PLoS One. 2015 Mar 04;10(3):e0118432
pubmed: 25738806
N Engl J Med. 2017 Jun 29;376(26):2507-2509
pubmed: 28657867